Trend-Following Backtester · Guide · backtest 한국어

etf · HK

CSOP Hang Seng Biotech ETF backtest

10 trend-following strategies were compared on the full daily history of CSOP Hang Seng Biotech ETF. 10 beat buy-and-hold CAGR; 볼린저 밴드 돌파 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 3.9%, MDD -8.9%).

Data 2021-07-21 ~ 2026-07-31daily bars 1,234 (5.0 years)Costs 0.5%Venue HKEXMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -15.5%, drawdown -79.5%).

Sharpe leader (same as main): 볼린저 밴드 돌파 — CAGR 11.6%, MDD -24.5%, Sharpe 0.73, 12% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 27.1%p higher than buy and hold, while drawdown improves by 55.0%p (CAGR 3.9%, MDD -8.9%, exposure 5%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
볼린저 밴드 돌파
n=27, k=2.8
11.6%-24.5%0.730.471.7x812%
ROC 모멘텀
n=200, threshold=0.14
10.7%-25.0%0.620.431.7x1025%
Donchian 채널 돌파
entryN=66, exitN=75
11.1%-32.6%0.570.341.7x432%
Keltner 채널 돌파
emaPeriod=43, atrPeriod=22, mult=2.4
10.2%-27.7%0.550.371.6x1425%
SMA 크로스오버
fast=41, slow=234
9.3%-32.4%0.520.291.6x434%
ADX / DI 방향성
period=32, threshold=20
3.9%-8.9%0.500.441.2x105%
EMA 크로스오버
fast=46, slow=65
4.2%-36.1%0.300.121.2x1230%
Supertrend
period=37, mult=3.9
1.3%-43.5%0.190.031.1x2742%
Parabolic SAR
step=0.01, maxStep=0.08
-6.1%-50.6%-0.08-0.120.7x5841%
MACD
fast=18, slow=50, signal=17
-7.9%-56.6%-0.13-0.140.7x5148%
Buy and hold-15.5%-79.5%-0.19-0.190.4x1100%
1x 2022 2023 2024 2025 2026 볼린저 밴드 돌파Buy and hold
볼린저 밴드 돌파: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -20% -40% -60% -80% 2022 2023 2024 2025 2026 Buy and hold볼린저 밴드 돌파
볼린저 밴드 돌파 maximum drawdown -24.5% (2024-10-07 → 2025-02-13), recovered after 281 days.

Rules of the top strategy

Breaking above the upper band (average plus a multiple of volatility) signals a strong move up.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next